Immunological crossreactivity between a cloned antigen of Onchocerca volvulus and a component of the retinal pigment epithelium

G Braun, N M McKechnie, V Connor, C E Gilbert, F Engelbrecht, J A Whitworth, D W Taylor, G Braun, N M McKechnie, V Connor, C E Gilbert, F Engelbrecht, J A Whitworth, D W Taylor

Abstract

Onchocerciasis (river blindness) is a major blinding disease in Africa, Central America, and South America. Loss of vision can be due to corneal change, optic atrophy, or chorioretinal disease. It has been suggested that autoimmunological reactions resulting from crossreactivity between parasite antigens and components of eye tissues contribute to development of ocular pathology. Using sera collected from onchocerciasis patients as a screening reagent, a cDNA clone (Ov39) has been isolated from a lambda gt11 expression library of Onchocerca volvulus. This antigen exhibits immunological crossreactivity with a component of retinal pigment epithelium cells (RPE). Antiserum raised against this recombinant peptide immunoprecipitates a 22,000 Mr antigen of adult O. volvulus and recognizes a 44,000 Mr component of bovine RPE by Western blotting. A 44,000 Mr antigen of cultured human RPE metabolically labeled with 35S-methionine can be immunoprecipitated with the same antiserum. An antigen of the same size is recognized by a rabbit antiserum raised against whole O. volvulus extract. Immunocytochemical studies on cryostat sections of the bovine eye using the antirecombinant sera localizes this antigen to the RPE.

References

    1. Trans R Soc Trop Med Hyg. 1976;70(5-6):374-7
    1. Gene. 1988 Nov 15;71(1):157-64
    1. Nature. 1970 Aug 15;227(5259):680-5
    1. Exp Eye Res. 1983 Sep;37(3):307-13
    1. Br J Ophthalmol. 1976 Jan;60(1):2-20
    1. Trans Ophthalmol Soc U K. 1980 Apr;100(Pt 1):179-85
    1. Am J Ophthalmol. 1973 Jan;75(1):82-9
    1. Immunology. 1988 Mar;63(3):545-50
    1. Invest Ophthalmol Vis Sci. 1990 Jul;31(7):1374-80
    1. J Biol Chem. 1978 Apr 10;253(7):2471-82
    1. Proc Natl Acad Sci U S A. 1983 Mar;80(5):1194-8
    1. Anal Biochem. 1984 Feb;137(1):266-7
    1. Acta Trop. 1978 Sep;35(3):269-79
    1. Br J Ophthalmol. 1955 Jun;39(6):321-32
    1. Arch Ophthalmol. 1971 Nov;86(5):557-63
    1. Clin Exp Immunol. 1989 Sep;77(3):367-72
    1. Am J Ophthalmol. 1984 Oct 15;98(4):519-21
    1. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4
    1. Br J Ophthalmol. 1958 Jan;42(1):21-37
    1. Trop Med Parasitol. 1988 Sep;39(3):260-8
    1. Mol Biochem Parasitol. 1987 Oct;25(3):247-55
    1. Ophthalmology. 1990 Oct;97(10):1334-41
    1. J Mol Biol. 1975 Nov 5;98(3):503-17
    1. Br Med J. 1954 Sep 25;2(4890):724-9
    1. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7
    1. Eur J Biochem. 1976 AUG 1;67(1):247-56
    1. Rev Infect Dis. 1985 Nov-Dec;7(6):820-5
    1. Nucleic Acids Res. 1984 Jan 25;12(2):857-72
    1. Ophthalmology. 1987 Apr;94(4):439-43
    1. Trans R Soc Trop Med Hyg. 1978;72(4):372-7
    1. Exp Eye Res. 1977;25 Suppl:27-63
    1. J Biol Chem. 1978 Apr 10;253(7):2483-95
    1. Invest Ophthalmol Vis Sci. 1985 Jan;26(1):1-9
    1. Proc Natl Acad Sci U S A. 1979 Aug;76(8):3683-7
    1. Tropenmed Parasitol. 1977 Dec;28(4):428-30
    1. Science. 1983 Nov 18;222(4625):778-82
    1. J Immunol. 1988 Mar 1;140(5):1490-5
    1. Mol Biochem Parasitol. 1988 Dec;31(3):241-50
    1. Bull World Health Organ. 1978;56(1):63-73
    1. Trop Med Parasitol. 1988 Dec;39 Suppl 4:460-2
    1. Br J Ophthalmol. 1980 Mar;64(3):191-200
    1. Tropenmed Parasitol. 1975 Sep;26(3):370-4
    1. Mol Biochem Parasitol. 1984 Mar;10(3):305-18
    1. Biochemistry. 1979 Nov 27;18(24):5294-9
    1. Acta Leiden. 1990;59(1-2):271-83
    1. Invest Ophthalmol Vis Sci. 1979 Nov;18(11):1172-84

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner